Table 2. Clinical features of participants with positive acute myeloblastic leukemia with maturation (AML-M2) with RUNX1/RUNX1T1.
| Most common signs and symptoms | Frequency (n) and percentages (%) | p-value |
| Pallor | 10 (83.3%) | 0.0001 |
| Weight loss | 8 (66.7%) | |
| Splenomegaly | 7 (58.3%) | |
| Palpitation | 6 (50.0%) | |
| Bone pain | 5 (41.6%) | |
| Infections | 5 (41.6%) | |
| Lymph node enlargements | 4 (33.3%) | |
| Fatigue | 2 (16.7%) | |
| Bruises | 1 (8.3%) | |
| Fever | 9 (75.0%) | |
| Gum bleeding | 7 (58.3%) | |
| Breathlessness | 6 (50.0%) | |
| Body ache | 6 (50.0%) | |
| Skin petechiae | 5 (41.7%) | |
| Gums swelling | 4 (33.3%) | |
| Nose bleeding | 3 (25.0%) | |
| Liver enlargement | 2 (16.6%) | |
| Disseminated intravascular coagulation (DIC) | 1 (8.3%) |